Latest News Archive
Please select Category, Year, and then Month to display items
13 August 2024
|
Story Anthony Mthembu
|
Photo Sibahle Dayimani and Amandla Kulu
Prof Peter Roseel, Managing Director of Management Consulting and Research – a spin-off of the Catholic University of Leuven in Belgium; and Prof Nicolene Barkhuizen, Director of the UFS Business School.
The Business School at the University of the Free State (UFS) hosted Prof Peter Rosseel, Managing Director of Management Consulting and Research – a spin-off of the Catholic University of Leuven in Belgium – for a guest lecture during his visit to the UFS Faculty of Economic and Management Sciences (EMS).
The guest lecture took place on 19 July 2024 in the Business School Auditorium and was attended by academics from the UFS.
Reflecting on the lecture
The lecture presented by Prof Rosseel focused on how combining strategy, strategy implementation, culture transformation, leadership, and learning successfully leads to sustainable growth, creates engagement, and delivers tangible results. Throughout the lecture, Prof Rosseel spoke about how experts tend to make bad leaders and therefore stop change from happening within an organisation. In fact, he highlighted that, “Experts stop change from happening within the workplace because experts, by definition, look through the eyes of their expertise, but you cannot reduce the world to different forms of expertise, as it is holistic.” As such, he argued that to change an organisation, one must see things from the point of view of others.
Furthermore, Prof Rosseel delved deeper into the hierarchical operating model within organisations. He indicated that the above model should be one community within organisations; however, unfortunately it is not. This is because organisations are made up of several departments such as finance and human resources. As such, he regards these departments to be silos that could prove to be detrimental to organisations, as each silo can create its own culture as opposed to an organisational culture. These are some of the points he discussed throughout the lecture.
After the lecture concluded, the audience had the opportunity to engage with Prof Rosseel on his viewpoints. In fact, Lyle Markham, Academic Head of Department and Lecturer in Industrial Psychology at the UFS, was one of the audience members and described the lecture as insightful.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004